Immunoprecipitation of EGFR from EGF-treated A431 cells by Anti-EGFR (Phospho-Tyr992) Antibody (A86777) (A), Anti-EGFR (Phospho-Tyr1173) Antibody (A86778) (B), a commercial Anti-EGFR Antibody (C), and Anti-EGFR Antibody [mAb108] (D). The precipitates were immunoblotted with Anti-EGFR (Phospho-Tyr992) Antibody (A86777) or Anti-EGFR (Phospho-Tyr1173) Antibody (A86778), and Goat Anti-Mouse IgG (HRP).
Immunoprecipitation of EGFR from EGF-treated A431 cells by Anti-EGFR (Phospho-Tyr992) Antibody (A86777) (A), Anti-EGFR (Phospho-Tyr1173) Antibody (A86778) (B), a commercial Anti-EGFR Antibody (C), and Anti-EGFR Antibody [mAb108] (D). The precipitates were immunoblotted with a commercial Anti-EGFR Antibody and Goat Anti-Rabbit IgG (HRP).
Recombinant human monoclonal antibody to EGFR for use as a research grade Panitumumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant chimeric monoclonal antibody to EGFR for use as a research grade Modotuximab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to EGFR for use as a research grade Panitumumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant chimeric monoclonal antibody to EGFR for use as a research grade Modotuximab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.